(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...

This review seeks to familiarize the readers with RSV rapid antigen-detection tests, describe their performance characteristics and comment on their strengths and weaknesses. The authors will ...

Healthy infants born at a gestational age of at least 35 weeks who were aged younger than 1 year and entering their first RSV season were randomly assigned 2:1 to receive an intramuscular injection of ...

Hologic's Panther system, on which the assay runs, processes the samples, delivering initial outcomes in under three hours.

“Our COVID test was instrumental in addressing ... In November 2024, the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay was expanded for use with anterior nasal swabs transported via enhanced ...

GSK will start preparations for regulatory filings of its respiratory syncytial virus (RSV ... have also reached the final stage of clinical testing. Moderna meanwhile has also said it intends ...

The acquisition focuses on sisunotavir, an RSV fusion inhibitor that UK-based ReViral has taken into phase 2 clinical testing, with a breakthrough designation from the FDA. Last year, the first ...

In light of Pope Francis’ latest diagnosis, Dr. Leana Wen explains why older adults are especially at risk for serious ...

This seasonal shift was linked to SARS-CoV-2 public health measures. We examine the epidemiology and RSV testing of respiratory-coded admissions, and compare clinical phenotype of RSV-positive ...

Methods that improve RSV RADT analytical sensitivity (viral titer threshold for test detection) and clinical sensitivity (proportion of true-positive infections detected) must be developed and ...